Jejuni In Chickens Research Articles

B lymphocytes play a limited role in clearance of Campylobacter jejuni from the chicken intestinal tract

Campylobacter jejuni is the leading cause of foodborne bacterial gastroenteritis with contaminated poultry meat its main source. Control of C. jejuni is a priority for the poultry industry but no vaccines are available and their development hampered by poor understanding of the immunobiology of C. jejuni infection. Here we show the functional role of B lymphocytes in response to C. jejuni in the chicken through depletion of the B lymphocyte population (bursectomy) followed by challenge. B lymphocyte depletion has little effect on bacterial numbers in the ceca, the main site of colonisation, where C. jejuni persist to beyond commercial slaughter age, but reduces clearance from the small intestine. In longer-term experiments we show antibody leads to reduction in C. jeuni numbers in the ceca by nine weeks post infection. Whilst we did not examine any protective role to re-challenge, it illustrates the difficulty in producing a vaccine in a young, immunologically naïve host. We believe this is first study of functional immunity to C. jejuni in chicken and shows antibody is ineffective in clearing C. jejuni from the ceca within the production lifetime of chickens, although is involved in clearance from the small intestine and longer-term clearance from the ceca.

Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine.

Campylobacter jejuni is a predominant cause of human gastroenteritis worldwide. Source-attribution studies indicate that chickens are the main reservoir for infection, thus elimination of C. jejuni from poultry would significantly reduce the burden of human disease. We constructed glycoconjugate vaccines combining the conserved C. jejuni N-glycan with a protein carrier, GlycoTag, or fused to the Escherichia coli lipopolysaccharide-core. Vaccination of chickens with the protein-based or E. coli-displayed glycoconjugate showed up to 10-log reduction in C. jejuni colonization and induced N-glycan-specific IgY responses. Moreover, the live E. coli vaccine was cleared prior to C. jejuni challenge and no selection for resistant campylobacter variants was observed. Analyses of the chicken gut communities revealed that the live vaccine did not alter the composition or complexity of the microbiome, thus representing an effective and low-cost strategy to reduce C. jejuni in chickens and its subsequent entry into the food chain.

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines.

The World Health Organization has indicated that we are entering into a post-antibiotic era in which infections that were routinely and successfully treated with antibiotics can now be lethal due to the global dissemination of multidrug resistant strains. Conjugate vaccines are an effective way to create a long-lasting immune response against bacteria. However, these vaccines present many drawbacks such as slow development, high price, and batch-to-batch inconsistencies. Alternate approaches for vaccine development are urgently needed. Here we present a new vaccine consisting of glycoengineered outer membrane vesicles (geOMVs). This platform exploits the fact that the initial steps in the biosynthesis of most bacterial glycans are similar. Therefore, it is possible to easily engineer non-pathogenic Escherichia coli lab strains to produce geOMVs displaying the glycan of the pathogen of interest. In this work we demonstrate the versatility of this platform by showing the efficacy of geOMVs as vaccines against Streptococcus pneumoniae in mice, and against Campylobacter jejuni in chicken. This cost-effective platform could be employed to generate vaccines to prevent infections caused by a wide variety of microbial agents in human and animals.

Incidence of Campylobacter jejuni in Chicken’s Meat and Faeces in Kano Metropolis, Kano State, Nigeria

Incidence of Campylobacter jejuni in Chicken’s Meat and Faeces in Kano Metropolis, Kano State, Nigeria

Chicken Caecal Microbiome Modifications Induced by Campylobacter jejuni Colonization and by a Non-Antibiotic Feed Additive.

Campylobacter jejuni is an important zoonotic foodborne pathogen causing acute gastroenteritis in humans. Chickens are often colonized at very high numbers by C. jejuni, up to 109 CFU per gram of caecal content, with no detrimental effects on their health. Farm control strategies are being developed to lower the C. jejuni contamination of chicken food products in an effort to reduce human campylobacteriosis incidence. It is believed that intestinal microbiome composition may affect gut colonization by such undesirable bacteria but, although the chicken microbiome is being increasingly characterized, information is lacking on the factors affecting its modulation, especially by foodborne pathogens. This study monitored the effects of C. jejuni chicken caecal colonization on the chicken microbiome in healthy chickens. It also evaluated the capacity of a feed additive to affect caecal bacterial populations and to lower C. jejuni colonization. From day-0, chickens received or not a microencapsulated feed additive and were inoculated or not with C. jejuni at 14 days of age. Fresh caecal content was harvested at 35 days of age. The caecal microbiome was characterized by real time quantitative PCR and Ion Torrent sequencing. We observed that the feed additive lowered C. jejuni caecal count by 0.7 log (p<0.05). Alpha-diversity of the caecal microbiome was not affected by C. jejuni colonization or by the feed additive. C. jejuni colonization modified the caecal beta-diversity while the feed additive did not. We observed that C. jejuni colonization was associated with an increase of Bifidobacterium and affected Clostridia and Mollicutes relative abundances. The feed additive was associated with a lower Streptococcus relative abundance. The caecal microbiome remained relatively unchanged despite high C. jejuni colonization. The feed additive was efficient in lowering C. jejuni colonization while not disturbing the caecal microbiome.

Use of Caprylic Acid in Broiler Chickens: Effect on Campylobacter jejuni.

The effect of caprylic acid (CA) on Campylobacter jejuni in chickens was evaluated using two approaches: dietary supplementation or surface treatment of chilled chicken carcasses. To analyze the dietary effect of CA, individually housed broiler chickens (n = 48) were artificially infected with C. jejuni VFU612 (10(6) colony-forming units [CFU]/bird) on the 21st and 35th days of life. Dietary CA (2.5 and 5 g/kg of feed, fed throughout the entire experiment) significantly decreased C. jejuni shedding (p<0.05). However, the effect only lasted for 3-7 days after infection. The numbers of Campylobacter shed by the positive control birds reached its maximum on the 37th day of life, while on that same day, both Treatment I and Treatment II groups shed significantly lower (p<0.05) numbers of Campylobacter (by 0.8 and 1.8 log10 CFU/g, respectively). Also, peak shedding was delayed by 1 day in both treated groups. After euthanasia of each chicken on the 42nd day of life, no differences in Campylobacter counts in the crop, gizzard, ileum, and cecum were found between the positive control and the treated groups (p>0.05). Surface contamination of the chilled chicken halves was performed with C. jejuni VFU612 (clinical isolate) and CCM6214 (collection strain). Surface treatment with CA at 1.25 and 2.5 mg/mL for 1 min significantly reduced C. jejuni VFU612 contamination of chicken skin (p<0.05) by 0.29-0.53 and 1.14-1.58 log10 CFU/g of skin, respectively. Counts of C. jejuni CCM6214 were reduced by 0.68-1.65 log10 CFU/g of skin). In conclusion, dietary CA affected numbers of C. jejuni in the gastrointestinal contents of chickens, whereas surface treatment reduced C. jejuni contamination in processed chicken carcasses.

Extensive characterization of Campylobacter jejuni chicken isolates to uncover genes involved in the ability to compete for gut colonization.

BackgroundCampylobacter jejuni is responsible for human foodborne enteritis. This bacterium is a remarkable colonizer of the chicken gut, with some strains outcompeting others for colonization. To better understand this phenomenon, the objective of this study was to extensively characterize the phenotypic performance of C. jejuni chicken strains and associate their gut colonizing ability with specific genes.ResultsC. jejuni isolates (n = 45) previously analyzed for the presence of chicken colonization associated genes were further characterized for phenotypic properties influencing colonization: autoagglutination and chemotaxis as well as adhesion to and invasion of primary chicken caecal cells. This allowed strains to be ranked according to their in vitro performance. After their in vitro capacity to outcompete was demonstrated in vivo, strains were then typed by comparative genomic fingerprinting (CGF). In vitro phenotypical properties displayed a linear variability among the tested strains. Strains possessing higher scores for phenotypical properties were able to outcompete others during chicken colonization trials. When the gene content of strains was compared, some were associated with different phenotypical scores and thus with different outcompeting capacities. Use of CGF profiles showed an extensive genetic variability among the studied strains and suggested that the outcompeting capacity is not predictable by CGF profile.ConclusionThis study revealed a wide array of phenotypes present in C. jejuni strains, even though they were all recovered from chicken caecum. Each strain was classified according to its in vitro competitive potential and its capacity to compete for chicken gut colonization was associated with specific genes. This study also exposed the disparity existing between genetic typing and phenotypical behavior of C. jejuni strains.Electronic supplementary materialThe online version of this article (doi:10.1186/s12866-015-0433-5) contains supplementary material, which is available to authorized users.

Evaluation of passive immunotherapeutic efficacy of hyperimmunized egg yolk powder against intestinal colonization of Campylobacter jejuni in chickens

Campylobacter jejuni is a leading cause of foodborne bacterial gastroenteritis in human. Chickens are the reservoir host of C. jejuni, and contaminated chicken meat is an important source of human infection. Therefore, control of C. jejuni in chickens can have direct effect on human health. In this study we tested the passive immunotherapeutic efficacy of the chicken egg-yolk-derived antibodies, in the form of hyperimmunized egg yolk powder (HEYP), against 7 colonization-associated proteins of C. jejuni, namely, CadF (Campylobacter adhesion to fibronectin), FlaA (flagellar proteins), MOMP (major outer membrane protein), FlpA (fibronectin binding protein A), CmeC (Campylobacter multidrug efflux C), Peb1A (Campylobacter putative adhesion), and JlpA (Jejuni lipoprotein A). Three chicken experiments were performed. In each experiment, chickens were treated orally via feed supplemented with 10% (wt/wt) egg yolk powder. In experiment 1, chicken groups were experimentally infected with C. jejuni (108 cfu) followed by treatment with 5 HEYP (CadF, FlaA, MOMP, FlpA, CmeC) for 4 d either individually or as a cocktail containing equal parts of each HEYP. In experiment 2, chickens were treated for 21 d with cocktail containing equal parts of 7 HEYP before and after experimental infection with C. jejuni (108 cfu). In experiment 3, chickens were treated with feed containing a cocktail of 7 HEYP before and after (prophylaxis), and after (treatment) experimental infection with C. jejuni (105 cfu). Intestinal colonization of C. jejuni was monitored by culturing cecal samples from chickens euthanized at the end of each experiment. The results showed that there were no differences in the cecal colonization of C. jejuni between HEYP treated and nontreated control chickens, suggesting that use of HEYP at the dose and the regimens used in the current study is not efficacious in reducing C. jejuni colonization in chickens.

Rapid and Simultaneous Detection of Salmonella and Campylobacter in Poultry Samples Using Quantum Dots Based Fluorescent Immunoassay Coupled with Magnetic Immunoseparation

Salmonella Typhimurium and Campylobacter jejuni are the most important bacterial pathogens associated with food borne diseases caused by consuming undercooked poultry or handling raw poultry and poultry products. Because of their low infectious dose of pathogens, a rapid, sensitive, simultaneous detection method is urgently needed. The objective of our research was to develop a sensitive biosensing method for rapid and simultaneous detection of S. Typhimurium and C. jejuni in chicken and ground turkey meat using magnetic nanobeads (MNBs) to capture and separate the target bacteria and quantum dots (QDs) to label the captured bacteria. In this research, both streptavidin conjugated QDs 530 and QDs 620 were coated with the specific biotin conjugated anti-S. Typhimurium and anti-C. jejuni antibodies, respectively. The MNBs were separately coated with the specific biotin conjugated anti-S. Typhimurium and anti-C. jejuni antibodies. The inoculated poultry samples were mixed with conjugated MNBs to capture the two target bacteria. After magnetic immunoseparation, the MNB-cell complexes were mixed with the conjugated QDs 530 and QDs 620 to form the MNB-cell-QD complexes. Unattached conjugated QDs were removed using magnetic separation. Finally, the fluorescence intensities of the MNB-S. Typhimurium-QD and MNB-C. jejuni-QD complexes were measured and correlated to the cell number of two target pathogens. The results showed that S. Typhimurium and C. jejuni in pure culture, chicken carcass and ground turkey wash solutions could be simultaneously separated and detected using the developed immunoassay. The fluorescence intensities at 530 and 620 nm wavelengths increased linearly with the increasing cell numbers of S. Typhimurium and C. jejuni, respectively. The assay detection limit was 30-50 cfu/ml and the assay time was less than 2 h.

Effects of feeding plant-derived agents on the colonization of Campylobacter jejuni in broiler chickens

The aim of this work was to test the potential use of plant-derived extracts and compounds to control Campylobacter jejuni in broiler chickens. Over a 7-wk feeding period, birds were fed a commercial diet with or without plant extracts (Acacia decurrens, Eremophila glabra), essential oil [lemon myrtle oil (LMO)], plant secondary compounds [terpinene-4-ol and α-tops (including α-terpineol, cineole, and terpinene-4-ol)], and the antibiotic virginiamycin. Traditional culture and real-time quantitative PCR techniques were used to enumerate the numbers of C. jejuni in chicken fecal and cecal samples. In addition, BW and feed intake were recorded weekly for the calculation of BW gain and feed conversion ratio. The mean log10 counts of C. jejuni were similar (P > 0.05) across treatments. However, significantly lower levels of fecal Campylobacter counts (P < 0.05) were recorded at d 41 for the α-tops treatment by culture methods. No differences (P > 0.05) in BW gain were obtained for dietary supplementation, except for the E. glabra extract, which had a negative impact (P < 0.001) on BW, resulting in sporadic death. Results from this study suggest that supplemental natural compounds used in the current study did not reduce the shedding of C. jejuni to desired levels.

Prevalence of Campylobacter jejuni in chicken produced by major poultry companies in Saudi Arabia

Abstract Background Campylobacter is a foodborne pathogen that is commonly associated with chicken. The aim of this work was to evaluate the prevalence of Campylobacter jejuni (as affected by refrigerated storage) in chicken samples obtained from the wholesale poultry market in the northern part of Riyadh City, Saudi Arabia. Findings A gradual increase in the number of positive samples was noted during storage at 4°C. On days 1, 3, and 7, the number of positive samples were 10 (30.305%), 15 (45.45%), and 27 (81.81%), respectively. Of 99 tested samples, 52 (52.25%) were positive for Campylobacter jejuni. Protein profiling by Sodium dodecyl sulfate -Polyacrylamide gel electrophoresis (SDS-PAGE) was used to identify Campylobacter jejuni. The results were verified using Analytical Profile Index (API Campy system, Marcy l’Etoile, France). Forty-three (82.69%) positive isolates were identified as C. jejuni subsp. jejuni 2, 5 isolates as C. jejuni subsp. jejuni 1 (9.61%), and 4 isolates as C. jejuni subsp. doylei (7.69). Conclusion C. jejuni positive samples increased rapidly during storage at 4°C for approximately 1 wk. Our results also indicated a connection between the protein profiles on SDS-PAGE and API Campy used for the identification of C. jejuni.

Intestinal Carriage and Excretion of Campylobacter jejuni in Chickens Exposed at Different Ages

Campylobacter jejuni is usually recovered from chickens in commercial broiler farms after 2 to 3 weeks of age. This study was conducted to clarify whether fecal excretion is associated with the age of exposure to this bacterium. Day-of-hatch broiler chickens were separated from a flock in a local commercial farm, kept in isolation rooms, and esophageally inoculated with C. jejuni (5.5 × 107 to 5.4 × 108 CFU) at 0, 7, 14, 21, 28, and 35 days of age. The remaining chicks were placed on the farm. Fecal samples obtained from the birds with the experimental infection and those reared on the farm were monitored for C. jejuni. Cecal contents obtained on necropsy were also cultured. In chickens inoculated with C. jejuni at 0 to 14 days of age, fecal excretion of C. jejuni was not observed until 42 days of age, although the organism was recovered from the cecal contents of these birds. When chickens were inoculated at 21 to 35 days of age, C. jejuni was isolated from fecal samples 2 or 3 days after inoculation, and the birds continually shed the organism until they reached 49 days of age, with the maximal numbers of the organism ranging from 1.7 × 108 to 1.0 × 1010 CFU/g. In the commercial broiler farm, C. jejuni was first isolated from fecal samples obtained from two of five chickens at 28 days of age, and the organism was isolated from all five birds tested at 43 days of age. Restriction fragment length polymorphism analysis of the fla gene of C. jejuni isolates revealed that birds on the farm were colonized with C. jejuni after placement of the chickens on the farm. These observations indicate that chickens younger than 2 to 3 weeks old may carry C. jejuni in the ceca if they were exposed to this organism. Our results also suggest that fecal excretion of C. jejuni in commercial broiler chickens older than 3 to 4 weeks of age may be mainly caused by exposure of chickens at this age to this organism.

Virulence characteristics of five new Campylobacter jejuni chicken isolates

Campylobacter enteritis has emerged as one of the most common forms of human diarrheal illness. In this study we have investigated the virulence potential of five new C. jejuni chicken isolates (RO14, RO19, RO24, RO29 and RO37) originated from private households in the rural regions of Banat and Transylvania in Romania. Following isolation and in vitro virulence assay, on HCT-8 cells, our results show that all the C. jejuni chicken isolates overcome the virulence abilities of the highly virulent strain C. jejuni 81-176. Motility, an important virulence factor was significantly improved in all the new chicken isolates. The ability to survive to the antimicrobial activity of the human serum, to resist to the violent attack of bile acids and to survive in the presence of synthetic antibiotics was increased in all the chicken isolates. However, these were statistically significant only for isolates RO29 and RO37. In conclusion our study shows, based on invasiveness and motility, and also on the data provided by the serum and bile resistance experiments that all the new chicken isolates are able to infect human cells, in vitro, and could potentially represent a health hazard for humans.

Prevalence and Risk Assessment of Campylobacter jejuni in Chicken in China

ObjectiveTo understand the occurrence and distribution of Campylobacter jejuni in chicken in China, assess its health risk to the Chinese population, and provide recommendations for effective risk control. MethodsData from the National Food Safety Risk Surveillance Network on Campylobacter jejuni between 2007 and 2010 and from published articles were analyzed. Eleven parameters were used based on the whole chicken preparation process and prevalence of Campylobacter jejuni for risk assessment by using the Ross-Sumner Method. ResultsThe detection rates of Campylobacter jejuni in raw chicken were between 0.29% and 2.28% during 2007-2010 in China (more than 20 provinces). The probability of illness caused by Campylobacter jejuni due to chicken consumption was around six out of one million consumers per day in urban areas and around one out of one million consumers per day in rural areas. Total predicted illnesses per year was about 736 000, accounting for 1.6‰ of the general population in urban areas and about 301 000, accounting for 0.37‰ of the total population in rural areas. The risk rankings of Campylobacter jejuni in chicken were 52 and 49 in urban and rural areas, respectively. ConclusionA high risk score for Campylobacter jejuni in chicken was obtained in China. This result may contribute to development of food safety management strategies. Key efforts should be made to control the risk of Campylobacter jejuni in chicken in China, especially in chick breeding and chicken preparation processes.

Distribution of Colonization and Antimicrobial Resistance Genes in Campylobacter jejuni Isolated from Chicken

Campylobacter jejuni is an important worldwide foodborne pathogen commonly found as a commensal organism in poultry that can reach high numbers within the gut after colonization. Although information regarding some genes involved in colonization is available, little is known about their distribution in strains isolated specifically from chickens and whether there is a linkage between antimicrobial resistance (AMR) and colonization genes. To assess the distribution and relevance of genes associated with chicken colonization and AMR, a C. jejuni microarray was created to detect 254 genes of interest in colonization and AMR including variants. DNA derived from chicken-specific Campylobacter isolates collected in 2003 (n=29) and 2008 (n=28) was hybridized to the microarray and compared. Hybridization results showed variable colonization-associated gene presence. Acquired AMR genes were low in prevalence whereas chemotaxis receptors, arsenic resistance genes, as well as genes from the cell envelope and flagella functional groups were highly variable in their presence. Strains clustered into two groups, each linked to different control strains, 81116 and NCTC11168. Clustering was found to be independent of collection time. We also show that AMR weakly associated with the CJ0628 and arsR genes. Although other studies have implicated numerous genes associated with C. jejuni chicken colonization, our data on chicken-specific isolates suggest the opposite. The enormous variability in presumed colonization gene prevalence in our chicken isolates suggests that many are of lesser importance than previously thought. Alternatively, this also suggests that combinations of genes may be required for natural colonization of chicken intestines.

Microbial mechanisms of tolerance to weak acid stress

Microbial mechanisms of tolerance to weak acid stress

Survival of Campylobacter jejuni in chicken meat at frozen storage temperatures

The aim of this study was to determine the survival of Campylobacter jejuni in chicken meat samples at frozen temperatures and given length of incubation and to determine the impact of aerobic bacteria on the survival of C. jejuni. The chicken meat samples were inoculated with C. jejuni NCTC 11351 suspensions and stored in bags at temperatures of -20°C and -70°C. The mean value of C. jejuni from meat samples decreased from 7.52 log10 CFU/g after 30 minutes of incubation at ambient temperature, to 3.87 log10 CFU/g on the eighth week of incubation at -20°C, and to 3.78 log10 CFU/g at incubation at -70°C after the same incubation period. Both freezing temperatures, -20°C and -70°C, decreased the number of campylobacters. The presence of aerobic mesophilic bacteria did not influence the survival of C. jejuni in chicken meet samples. Keeping poultry meat at freezing temperatures is important for the reduction of C. jejuni, which has a strong influence on the prevention of occurrence of campylobacteriosis in humans.

Phase variable genes of Campylobacter jejuni exhibit high mutation rates and specific mutational patterns but mutability is not the major determinant of population structure during host colonization

Phase variation of surface structures occurs in diverse bacterial species due to stochastic, high frequency, reversible mutations. Multiple genes of Campylobacter jejuni are subject to phase variable gene expression due to mutations in polyC/G tracts. A modal length of nine repeats was detected for polyC/G tracts within C. jejuni genomes. Switching rates for these tracts were measured using chromosomally-located reporter constructs and high rates were observed for cj1139 (G8) and cj0031 (G9). Alteration of the cj1139 tract from G8 to G11 increased mutability 10-fold and changed the mutational pattern from predominantly insertions to mainly deletions. Using a multiplex PCR, major changes were detected in ‘on/off’ status for some phase variable genes during passage of C. jejuni in chickens. Utilization of observed switching rates in a stochastic, theoretical model of phase variation demonstrated links between mutability and genetic diversity but could not replicate observed population diversity. We propose that modal repeat numbers have evolved in C. jejuni genomes due to molecular drivers associated with the mutational patterns of these polyC/G repeats, rather than by selection for particular switching rates, and that factors other than mutational drift are responsible for generating genetic diversity during host colonization by this bacterial pathogen.

Survival of Campylobacter jejuni in chicken meat, chicken skin and chicken liver at low temperatures

The aim of this study was to determine survival of Campylobacter jejuni (C. jejuni) in chicken meat, chicken skin medallions and chicken liver contaminated with this bacterium at +4 °C and -20 °C, after 24 hours of incubation. The survival of C. jejuni at +4 °C, -20 °C in chicken meat, chicken skin medallions and chicken liver were examined after 24 hours of incubation with C. jejuni. All samples were previously tested for the presence of Campylobacter species according to ISO 10272-1:2006. After 24 hours of incubation at +4 ° C, the number of survived C. jejuni in chicken meat slightly decreased on both non-selective and selective plates, but still in range of 10. After 24 hours of incubation at -20 ° C, the number of survived C. jejuni in chicken meat was in range of 10 cfu/ml on non-selective plate, with complete absence of growth on selective plate. After 24 hours of incubation, the number of survived C. jejuni in chicken liver increased on selective and non-selective plates (>10) at +4 ° C, while at -20 ° C there were no C. jejuni survived on both plates. 24 hours of incubation at both temperatures did not much influence the number of C. jejuni in chicken meet, while chicken skin medaillons allowed increase of the number of bacteria. Incubation of chicken liver at + 4° C allowed bacterial multiplication, while incubation at -20 ° C caused absence of survival (Tab. 1, Ref. 12).

PERSPECTIVES ON THE USE OF ESSENTIAL OILS AS ANTIMICROBIALS AGAINST CAMPYLOBACTER JEJUNI CECT 7572 IN RETAIL CHICKEN MEATS PACKAGED IN MICROAEROBIC ATMOSPHERE

ABSTRACTThe chemical composition of the essential oils (EOs) of Inula graveolens, Laurus nobilis, Pistacia lentiscus and Satureja montana was analyzed using a gas chromatography‐mass spectrometry technique. The main components of EOs obtained were, respectively, bornyl acetate, 1,8‐cineole, β‐myrcene and carvacrol. EOs were screened for their ability to inhibit the growth of Campylobacter jejuni CECT 7572 using the standard agar‐disk diffusion assay. The results obtained, followed by measurements of minimal inhibitory concentrations, indicated that I. graveolens was most active (Φ = 53.3 mm), with the lowest MIC value against C. jejuni (2 µL/mL). EOs were tested in chicken stored in microaerobic conditions at 3 ± 2C, experimentally inoculated with the pathogen at a level of 5 × 105 cfu/g. C. jejuni counts in treated samples were 0.7–4.7 log10 cfu/g lower (P &lt; 0.05) than the controls throughout storage. The latter reached numbers of about 8 log10 cfu/g after 1 week. Lipid oxidation (thiobarbituric acid reactive substances [TBARS]) and sensory freshness odor were also determined. Samples treated with any EO had the lowest TBARS values (P &lt; 0.05). The presence of EOs significantly extended fresh meat odor. The results of the bioassays, together with the chemical profile of the EOs, support the possibility of using all EOs as potent natural preservatives to contribute in the reduction of experimentally inoculated C. jejuni in chicken meat.PRACTICAL APPLICATIONSThe results revealed for the first time in a chicken meat system the potential of I. graveolens, L. nobilis, P. lentiscus and S. montana EOs in inhibiting C. jejuni. This suggests the possibility that they, particularly I. graveolens, could be used as natural preservatives in chicken meat for reducing food hazards caused by this pathogen, which is now recognized as the leading cause of bacterial foodborne gastroenteritis.